Rivus to present data on new oral weight-loss drug that targets fat while saving muscle
Rivus Pharmaceuticals will present preclinical nonhuman primate and rodent data for RV-8451 at ObesityWeek 2026, with three poster presentations scheduled for 14-15 November in Washington, D.C. Poster abstracts announced by the company include a head-to-head comparison in obesity models in which RV-
<p>Rivus Pharmaceuticals will present preclinical nonhuman primate and rodent data for RV-8451 at ObesityWeek 2026, with three poster presentations scheduled for 14-15 November in Washington, D.C. Poster abstracts announced by the company include a head-to-head comparison in obesity models in which RV-</p>